Alexion Pharmaceuticals (United States)

Alexion Pharmaceuticals (United States)

Alexion Pharmaceuticals, Inc., a subsidiary of AstraZeneca, is a pharmaceutical company headquartered in Boston, Massachusetts, specializing in orphan drugs for rare diseases. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for Alexion Pharmaceuticals (United States), United States, covering academic research published from 2000 to 2025. Read More.


Open Access Percentage

56%


Total
Publications

1.2K


Total Open
Publications

665


Total
Citations

46K


Open Access
Percentage

56%


Total
Publications

1.2K


Total Open
Publications

665


Total
Citations

46K

Wikipedia

Website

download

Breakdown

17% 34% 5% 44%

Publisher Open

17%

Both

34%

Other Platform Open

5%

Closed

44%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
20002001200220032004200520062007200820092010201120122013201420152016201720182019202020212022202320242025

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

0102030405060708090100110Total Publications
20002001200220032004200520062007200820092010201120122013201420152016201720182019202020212022202320242025

Open

Closed

Publisher Open

43%OA Journal

OA Journal 43%

261

Hybrid 29%

173

No Guarantees 28%

172

Other Platform Open

Domain 82%

375

Institution 57%

259

Other Internet 7%

32

Preprint 4%

19

Public 1%

5

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
379
doaj.org OAI-PMH Repository
Institution
153
Royal Netherlands Academy of Arts and Sciences
Institution
26
Unknown Repository
Other Internet
19
Ghent University
Institution
17
Europe PMC
Domain
15
kuleuven.be OAI-PMH Repository
Institution
14
DOI
Other Internet
13
Erasmus University Rotterdam
Institution
9
California Digital Library
Institution
9
1 / 10

Data updated 12 August 2026

Share

Share

Share